Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AHRQ supports CER for complex patients

This article was originally published in The Gray Sheet

Executive Summary

Agency for Healthcare Research and Quality seeks grant applications through Jan. 20, 2010, for research on the comparative effectiveness of using different strategies to prevent and manage chronic illness in patients with "specific constellations of co-morbid conditions." AHRQ plans to spend up to $6 million from its American Recovery and Reinvestment Act of 2009 funds for the grants. Objectives include prioritizing evidence-based tests and treatments for patients with multiple physical or mental co-morbidities and suggesting changes in timing and frequency in prevention and treatment guidelines. AHRQ also wants to clarify how co-existing chronic conditions impact the comparative value of certain treatment or prevention strategies. The agency also seeks evidence that could help refine chronic-disease quality measures for complex and frail patients

You may also be interested in...

QUOTED. 6 April 2020. Bethany Hills.

Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.

Health And Wellness Trademark Review 31 March, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Faster, Better? Fujitsu, Polarisqb 'Quantum-Inspired' Tech Speeds Discovery

Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts